Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masoud Dara

Showing results (61-70 of 66) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 66 results.
Plos One|June 16, 2015
Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide StudyJamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov, et al.
AIDS and Behavior|July 13, 2020
Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with MenGlenn-Milo Santos, Benjamin Ackerman, Amrita Rao, et al.
The European Respiratory Journal|April 22, 2018
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 updateGiovanni Battista Migliori, Giovanni Sotgiu, Senia Rosales-Klintz, et al.
The European Respiratory Journal|September 26, 2015
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesHaileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Pageof 7

Showing results (61-70 of 66) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 66 results.
Plos One|June 16, 2015
Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide StudyJamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov, et al.
AIDS and Behavior|July 13, 2020
Economic, Mental Health, HIV Prevention and HIV Treatment Impacts of COVID-19 and the COVID-19 Response on a Global Sample of Cisgender Gay Men and Other Men Who Have Sex with MenGlenn-Milo Santos, Benjamin Ackerman, Amrita Rao, et al.
The European Respiratory Journal|April 22, 2018
ERS/ECDC Statement: European Union standards for tuberculosis care, 2017 updateGiovanni Battista Migliori, Giovanni Sotgiu, Senia Rosales-Klintz, et al.
The European Respiratory Journal|September 26, 2015
Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countriesHaileyesus Getahun, Alberto Matteelli, Ibrahim Abubakar, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|April 7, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility studyOnno Akkerman, Alena Aleksa, Jan-Willem Alffenaar, et al.
The European Respiratory Journal|October 12, 2019
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global reportSergey Borisov, Edvardas Danila, Andrei Maryandyshev, et al.
Pageof 7